Brilinta 90 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,876
Award facts
- Contract value 100% obligated
- $44,876.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $44,876.34 for 60 tablets of Brilinta 90 mg on January 8, 2026, with completion scheduled for January 9, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. Brilinta is a platelet aggregation inhibitor commonly prescribed for cardiovascular conditions, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need to support military and veteran healthcare systems with critical pharmaceutical products.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of prescription medications, generic drugs, vaccines, and medical supplies to military treatment facilities and federal healthcare institutions. As a major pharmaceutical distributor and the prime contractor on this significant IDC, AmerisourceBergen competes on a full and open basis, demonstrating its capability to efficiently fulfill essential pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQT9H?
SPE2DR26FQT9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FQT9H worth?
The government has obligated $44,876 on SPE2DR26FQT9H.
Is contract SPE2DR26FQT9H an order under another contract?
Yes. SPE2DR26FQT9H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT9H competed?
The extent of competition for SPE2DR26FQT9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award